BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3277171)

  • 1. Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases.
    Gonzatti-Haces M; Seth A; Park M; Copeland T; Oroszlan S; Vande Woude GF
    Proc Natl Acad Sci U S A; 1988 Jan; 85(1):21-5. PubMed ID: 3277171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human met oncogene is a member of the tyrosine kinase family.
    Gonzatti-Haces M; Park M; Dean M; Blair DG; Vande Woude GF
    Princess Takamatsu Symp; 1986; 17():221-32. PubMed ID: 3332011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The trk family of oncogenes and neurotrophin receptors.
    Lamballe F; Klein R; Barbacid M
    Princess Takamatsu Symp; 1991; 22():153-70. PubMed ID: 1844238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
    Comoglio PM
    EXS; 1993; 65():131-65. PubMed ID: 8380735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for non-covalent clusters of the c-met proto-oncogene product.
    Faletto DL; Tsarfaty I; Kmiecik TE; Gonzatti M; Suzuki T; Vande Woude GF
    Oncogene; 1992 Jun; 7(6):1149-57. PubMed ID: 1317541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation.
    Naldini L; Vigna E; Ferracini R; Longati P; Gandino L; Prat M; Comoglio PM
    Mol Cell Biol; 1991 Apr; 11(4):1793-803. PubMed ID: 2005882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase.
    Rodrigues GA; Park M
    Oncogene; 1994 Jul; 9(7):2019-27. PubMed ID: 8208547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of met oncogene activation.
    Park M; Dean M; Cooper CS; Schmidt M; O'Brien SJ; Blair DG; Vande Woude GF
    Cell; 1986 Jun; 45(6):895-904. PubMed ID: 2423252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of conserved residues in the tyrosine kinase domain of the human trk oncogene.
    Mitra G
    Oncogene; 1991 Dec; 6(12):2237-41. PubMed ID: 1837350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and biochemical characterization of p70TRK, product of the human TRK oncogene.
    Mitra G; Martin-Zanca D; Barbacid M
    Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6707-11. PubMed ID: 3477801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-mediated phosphorylation and protooncogene induction in Madin-Darby canine kidney cells.
    Hauguel-de Mouzon S; Kahn CR
    Mol Endocrinol; 1991 Jan; 5(1):51-60. PubMed ID: 1708099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-terminal truncated forms of Met, the hepatocyte growth factor receptor.
    Prat M; Crepaldi T; Gandino L; Giordano S; Longati P; Comoglio P
    Mol Cell Biol; 1991 Dec; 11(12):5954-62. PubMed ID: 1944272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor.
    Epstein RJ; Druker BJ; Roberts TM; Stiles CD
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10435-9. PubMed ID: 1359539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene.
    Bargmann CI; Weinberg RA
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5394-8. PubMed ID: 2899890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of the human trk oncogene.
    Martin-Zanca D; Mitra G; Long LK; Barbacid M
    Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 2():983-92. PubMed ID: 3472772
    [No Abstract]   [Full Text] [Related]  

  • 17. Colony-stimulating factor 1-mediated regulation of a chimeric c-fms/v-fms receptor containing the v-fms-encoded tyrosine kinase domain.
    Roussel MF; Downing JR; Ashmun RA; Rettenmier CW; Sherr CJ
    Proc Natl Acad Sci U S A; 1988 Aug; 85(16):5903-7. PubMed ID: 2842754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human met oncogene is related to the tyrosine kinase oncogenes.
    Dean M; Park M; Le Beau MM; Robins TS; Diaz MO; Rowley JD; Blair DG; Vande Woude GF
    Nature; 1985 Nov 28-Dec 4; 318(6044):385-8. PubMed ID: 4069211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protooncogene c-sea encodes a transmembrane protein-tyrosine kinase related to the Met/hepatocyte growth factor/scatter factor receptor.
    Huff JL; Jelinek MA; Borgman CA; Lansing TJ; Parsons JT
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6140-4. PubMed ID: 8392188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent generation of oncogenes by in vitro recombination of TRK protooncogene sequences.
    Oskam R; Coulier F; Ernst M; Martin-Zanca D; Barbacid M
    Proc Natl Acad Sci U S A; 1988 May; 85(9):2964-8. PubMed ID: 3362859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.